Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12116629 Methods and compositions for reducing nucleotide impurities

Patent 12116629 was granted and assigned to Singular genomics Systems, Inc. on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Singular genomics Systems, Inc.

Current Assignee

Singular genomics Systems, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121166290

Patent Inventor Names

Eli N. Glezer0

Abrehet Abdu0

Jiawen Li0

Laura Ann Hale0

Date of Patent

October 15, 2024

Patent Application Number

181881530

Date Filed

March 22, 2023

Patent Citations

‌

US Patent 9453258 Methods and compositions for nucleic acid sequencing

‌

US Patent 10822653 Nucleotide cleavable linkers and uses thereof

‌

US Patent 10738072 Nucleotide analogues

‌

US Patent 7057026 Labelled nucleotides

‌

US Patent 7541444 Modified nucleotides

‌

US Patent 8039817 Compensator for multiple surface imaging

‌

US Patent 8241573 Systems and devices for sequence by synthesis analysis

‌

US Patent 9222132 Methods and compositions for efficient base calling in sequencing reactions

Patent Primary Examiner

‌

Robert T. Crow

Patent abstract

Disclosed herein, inter alia, are compositions and methods for depleting nucleotide impurities in nucleotide solutions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12116629 Methods and compositions for reducing nucleotide impurities

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API